Pharmacology
Clinical Studies
Dosing and Administration
Warnings/Precautions/Safety
Potpourri
100

The elimination half life of fenfluramine

What is 20 hours?

100

Doses used in Study 1

What is 0.7 mg/kg/day and 0.2 mg/kg/day?

100

The initial starting dose without concomitant stiripentol 

What is 0.1 mg/kg twice daily?

100

The 2 most common adverse reactions that occurred in patients treated with Fintepla (incidence at least 10% and greater than placebo)

What is decreased appetite and somnolence/sedation/lethargy?

100

The contraindications of Fintepla

What is 

- Hypersensitivity to fenfluramine or any of the excipients in Fintepla

- Concomitant use of, or within 14 days of the administration on MAOIs because of an increased risk of serotonin syndrome

200

Time to maximum plasma concentration at steady state

What is 4 to 5 hours?

200

AEDs used in Study 2

What are stiripentol, clobazam, and valproate?

200

Maximum daily dose for patients taking concomitant stiripentol

What is 0.2 mg/kg twice daily?

200

Echocardiograms should be completed post-treatment in this timeframe

What is 3-6 months?

200

The flavor of Fintepla oral solution

What is cherry?

300

The Mechanism of Action of fenfluramine is believed to be

What is increasing the extracellular levels of serotonin through interaction with serotonin transporter proteins, and exhibit agonist activity at serotonin 5HT-2 receptors.

300

Minimum number of convulsive seizure that patients were required to have for inclusion in both Study 1 and Study 2 while on stable AED therapy

What is 6?

300

When discontinuing Fintepla, the dose should be _____

What is decreased gradually?

300

In clinical trials of up to 3 years, the number of patients receiving Fintepla that developed pulmonary arterial hypertension or valvular heart disease

What is zero?

300

The number of patients with Dravet Syndrome treated with Fintepla in controlled and uncontrolled trials for more than 2 years

What is 138?

400

The percentage of fenfluramine metabolized to nonfenfluramine prior to elimination

What is 75%?

400

Change in convulsive seizure frequency during the treatment period in patients with Dravet Syndrome for both doses in Study 1

What is 79.4% for 0.7 mg/kg/day and 30.4% for 0.2 mg/kg/day?

400

For patients not on concomitant stiripentol in whom a rapid titration is warranted, the dose may be increased this often

What is every 4 days?

400

By the end of the controlled studies, the percentage of patients treated with Fintepla had a measured decrease in weight of 7% or greater from their baseline weight

What is 19%?

400

The controlled substance schedule of Fintepla

What is schedule IV?

500

Change of AUC and Cmax of fenfluramine when a single 0.7 mg/kg dose of Fintepla was coadministered with a single dose of stiripentol, clobazam, and valproic acid combination

What is 69% and 18%?

500

The amount of time until a reduction in convulsive seizures was observed

What is 3 to 4 weeks?

500

Discard any unused Fintepla unused oral solution remaining after this amount of time of first opening the bottle or the "Discard After" date on the bottle, whichever is sooner

What is 3 months?

500

The Fintepla REMs phone number

What is 1-877-964-3649?

500

The maximum daily dosage in mg for patients not on concomitant stiripentol and on concomitant stiripentol, respectively

What is 26 mg and 17 mg?

M
e
n
u